EARLY BIRD REGISTRATION ENDS SEPTEMBER 1!
![shutterstock_2658171737 [Converted]_Smaller.jpg](https://static.wixstatic.com/media/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg/v1/fill/w_980,h_327,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/dcb143_8063f21dfa5b4fe6890ff40ca69c3d51~mv2.jpg)
Member Spotlight
Jen Torok, MSN, FNP-C
Jen Torok, MSN, FNP-C, is an interventional pain and obesity medicine-certified family nurse practitioner with more than 20 years of experience specializing in chronic pain, obesity medicine, metabolic health, and lifestyle medicine. She currently practices with Axis Spine Center and is the founder of Fiercely Connected Wellness, where she empowers individuals through evidence-based wellness and lifestyle strategies. A nationally recognized speaker, course director, and mentor, Jen is passionate about advancing education and leadership opportunities for advanced practice providers in pain medicine. Outside of work, she enjoys spending time with her family and inspiring others to live healthier, fuller lives.
INDUSTRY NEWS
Will recent FDA approval of a novel
nonopioid analgesic be a game changer?
Physician's Weekly
The Food and Drug Administration recently approved Journavx, a first-in-class oral, nonopioid, highly selective sodium channel blocker indicated as a treatment for adults with moderate to severe acute pain. Clinical data revealed that this agent is an effective, well-tolerated medicine without evidence of addictive potential, indicated for use with all types of moderate to sever acute pain.
